AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology.

Our unique approach leverages quantum-inspired physics algorithms to power generative AI in designing novel drug candidates—without relying on experimental data. We already delivered several drug discovery successes within our internal pipeline and through collaborations with pharmaceutical companies.
Our most advanced programs are currently in vivo optimization.

AQEMIA is based in Paris and London.

AI/ML

Biotechnology

Chemicals

��

People (1)

Jobs (0)

Other offices

��������

People (1)

Jobs (0)

Other offices

��